1. Home
  2. NBN vs MLTX Comparison

NBN vs MLTX Comparison

Compare NBN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northeast Bank

NBN

Northeast Bank

HOLD

Current Price

$121.80

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$18.09

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBN
MLTX
Founded
1872
2021
Country
United States
Switzerland
Employees
234
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NBN
MLTX
Price
$121.80
$18.09
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$130.50
$27.50
AVG Volume (30 Days)
84.8K
793.8K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
0.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.77
N/A
Revenue Next Year
$18.72
N/A
P/E Ratio
$11.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$79.26
$5.95
52 Week High
$135.62
$62.75

Technical Indicators

Market Signals
Indicator
NBN
MLTX
Relative Strength Index (RSI) 49.82 53.86
Support Level $117.88 $15.50
Resistance Level $124.95 $19.16
Average True Range (ATR) 4.63 0.98
MACD -0.58 0.13
Stochastic Oscillator 17.59 40.48

Price Performance

Historical Comparison
NBN
MLTX

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: